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ABSTRACT: The present work describes a novel nano-
crystalline, multidoped hydroxyapatite featuring excellent
eukaryotic versus prokaryotic cell selectivity, attested by
excellent osteoinductive character and evaluated with human
stem cells, and anti-infective ability, tested against different
pathogens. Physicochemical analysis and transmission elec-
tron microscopy (TEM)/scanning STEM observations high-
lighted that such enhanced biological features are related to
the lower crystallinity level and increased surface charge of
hydroxyapatite, both induced by multiple-ion doping.
Specifically, the lattice substitution of Ca2+ with Zn2+
promotes the segregation of Ca2+ and doping Mg2+ cations
to a less-ordered surface layer, thus promoting dynamic ion
absorption/release acting as bioactive signals for cells and exerting an antiproliferative effect on all tested pathogens. These
findings open the design of new biodevices, combining regenerative ability and effective microbial inhibition without using any
antibiotic drugs. This is extremely important to circumvent bacterial resistance to antibiotics, which is today considered as one
of the biggest threats to global health.
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1. INTRODUCTION
Implantation of medical devices is a frequent surgical practice
which, however, is a gateway for pathogen contamination and
infections that are often at the basis of the implant failure.
Nowadays, this problem raises great concern, mostly due to the
bacterial resistance to antibiotic drugs, which is increasing at an
alarming rate. Owing to this, it is expected that in the coming
decades, nosocomial infections will not be effectively treated
by current drug-based protocols, thus leading to negative
impact on the clinical outcome of a steadily growing number of
patients, particularly those subjected to orthopedic prosthetic
surgery, in terms of longer hospital stays, higher medical costs,
and increased mortality.1,2 In this scenario, the development of
drug-free solutions as an alternative to systemic and intensive
administration of antibiotics and associated with therapeuti-
cally effective biomaterials is increasingly demanded. Most of
these solutions are based on the functionalization of
biomaterials with elements having antibacterial properties,
prominently silver or heavy metal nanoparticles.3 However, if
overdosed, these materials can result into cytotoxic and
genotoxic effects on healthy cells, and the correct dosage and
distribution of antibacterial nanoparticles are quite difficult to
define and apply.4−6 Striving to obtain more biocompatible
and safer compounds, calcium phosphates (CaPs) are
unanimously considered as elective materials to develop
devices for bone regeneration because of excellent biocompat-
ibility and osteoconductivity given by their close similarity with
the mineral bone composition. A recent study highlighted the
potential of CaPs as potential antibacterial agents, both against
various Gram-positive and Gram-negative strains, including
their multidrug-resistant analogues.7 Previous studies reported
the development of hydroxyapatite (HA) doped with ions such
as silver, copper, gallium, or zinc to improve antibacterial
properties and, particularly, in the case of zinc, to provide
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additional therapeutic effects.8−11 Multiple-ion doping is a
major characteristic of the natural bone tissue, particularly,
Mg2+ and CO3
2− ions are abundant (i.e. in extent ∼6 mol % for
Mg and 5−6 wt % for CO32−) in the immature bone as they
promote the formation of new bone mineral nuclei.12,13 Thus,
previous studies showed that synthetic ion-doped HA exhibits
enhanced bioactivity, particularly when doped with Mg2+ and
CO3
2− ions by wet synthesis methods.12,14,15 A previous study
reported that multidoped HA including Ga3+ ions was effective
in providing good osteogenic ability and anti-infective
protection.16 However, gallium is a toxic element not naturally
present in the human body, and its occurrence might give rise
to adverse reactions when administered in inappropriate doses.
The doping of HA with Zn2+ ions −present in the natural
bone as a trace element, that is, ∼0.2 wt %,17 was extensively
studied, given its ability to substitute Ca2+ ions in the HA
structure and to confer improved effects on cells, such as for
the restoration of bone metabolism during osteoporosis and
also to provide antibacterial properties.8,18 Zinc is of great
importance for many metabolic processes and is at the same
time a relatively harmless element;19 thus, many studies on Zn-
doped HA concerned Zn doping in much higher amounts with
respect to the physiological levels.8,20,21
The present work describes a nanocrystalline HA, prepared
for the first time by multiple doping with Zn2+, Mg2+, and
CO3
2− ions, to promote osteo-differentiation and to give
additional protection against microbial proliferation. The effect
of the doping ions on the physicochemical properties and, in
turn, on the HA bioactivity is evaluated in terms of
proliferation and osteogenic differentiation of human adi-
pose-derived stem cells. In a parallel experiment, in vitro
cultures of four pathogens, that is, Gram-positive bacteria
Staphylococcus aureus, Gram-negative bacteria Escherichia coli,
Pseudomonas aeruginosa, and yeast Candida albicans, which are
among the most common agents involved in nosocomial
infections,22−26 are carried out to assess the antimicrobial
ability of the new materials. This latter analysis is carried out
on both as-obtained and aged materials to evaluate bacterial
inhibition over a relatively long time lapse, relevant to face the
early critical postoperative period. The obtained results report
alteration of the crystal structure of HA induced by the
incorporation of Zn2+ and the other doping ions in the HA
lattice, yielding enhanced surface activity in multidoped
powders with respect to undoped HA and able to influence
the fate of cell and bacteria through biochemical signaling.
2. MATERIALS AND METHODS
2.1. Material Synthesis. Undoped and ion-doped HA phases
were synthesized by a neutralization method in aqueous environment
using ultrapure water (0.22 mS, 25 °C) to prevent the incorporation
of undesired foreign ions in the final product. Undoped HA was
synthesized as a reference material by preparing an aqueous
suspension of calcium hydroxide [Ca(OH)2, Sigma-Aldrich, 95%
purity], 10 g in 150 mL, and then neutralized with a solution of
phosphoric acid (H3PO4, Fluka, 85% purity), 9.72 g in 100 mL by
slow dripping (dripping rate = 1 drop/s). To achieve Zn2+ and Mg2+
ion doping in the apatite structure, zinc nitrate [Zn(NO3)2, Sigma-
Aldrich] and magnesium chloride hexahydrate (MgCl2·6H2O, Sigma-
Aldrich, 99.5% purity) were used. To dope the apatite with CO3
2−
ions, a solution of calcium bicarbonate (NaHCO3, Sigma-Aldrich)
was dropped in the alkaline suspension simultaneously with the
H3PO4 solution. In all the syntheses, the Ca/P ratio was set to 1.67,
that is, equal to that of stoichiometric HA. Single-doped HAs were
prepared with different Zn contents (i.e., Zn-HA-1 and Zn-HA-2),
whereas multidoped HA was obtained by adding Zn, Mg, and CO3
ions (i.e., Zn-MCHA). The synthesis process was carried out at 40 °C
to limit the HA crystal growth. The concentrations of the various ions
are indicated as XZn, XMg, and XCO3 [i.e., the molar ratios Zn/(Ca +
Mg + Zn), Mg/(Ca + Mg + Zn), and CO3/(CO3 + PO4),
respectively]. Nominal concentrations for the various doping ions are
Zn-HA-1: XZn = 0.05; Zn-HA-2: XZn = 0.10; Zn-MCHA: XZn = 0.05,
XMg = 0.05, and XCO3 = 0.15.
After the end of the dropping, the suspension was maintained
under stirring for 2 h to complete the reaction and homogenize the
product. Then, the stirring was stopped, and the suspension was left
overnight for maturation and sedimentation of the product. Then, the
supernatant liquid was removed, and the solid product was separated
by the residual fluid by centrifugation, repeatedly washed in bidistilled
water, and finally dried at 40 °C for 64 h. The dried powders were
manually milled, sieved below 106 μm, and stored in a dry
environment for further analysis.
2.2. Material Characterization. The phase composition of the
as-obtained materials was obtained by X-ray diffraction (XRD) with a
D8 ADVANCE (Bruker, Karlsruhe, Germany) diffractometer using
Cu Kα radiation (λ = 1.54178 Å) generated at 40 kV and 40 mA, a
counting time of 0.5 s, and a step size of 0.02° 2θ. Cell parameters and
crystallite size were assessed by the full profile analysis of the XRD
spectra (TOPAS 5, Bruker, Karlsruhe, Germany).
Infrared spectroscopy was performed on the as-obtained powders
by using a Nicolet 380 FTIR spectrometer (Thermo Fisher Scientific
Inc., Waltham, MA, US). The Fourier transform infrared (FTIR)
spectra were recorded on small pellets obtained by mixing 1 mg of the
sample powder with 150 mg of anhydrous potassium bromide (KBr).
The mixture was pressed at 108 g pressure into 7 mm diameter disks.
Before the acquisition of the FTIR spectra, the disks were heated at
100 °C for 24 h to expel the physically adsorbed water. A pure KBr
disk was used as blank.
The carbonate content was evaluated by thermogravimetric analysis
(TGA) of dried samples (∼10 mg) in the range of 600−1100 °C27
using a Stanton STA 1500 (Stanton, London, UK) analyzer with a
heating rate of 10 °C/min.
The chemical analysis was performed on dried samples (∼20 mg)
using inductively coupled plasma atomic emission spectroscopy
(ICP−OES, Agilent 5100, United States) and primary standards
(1000 ppm, Fluka). The samples were dissolved into 2 mL of nitric
acid then diluted in 100 mL of MilliQ water.
Microscopic investigation of the powders was carried out by field
emission gun scanning electron microscopy (SEM) (Sigma NTS
GmbH, Carl Zeiss, Oberkochen, Germany). The samples were placed
on an aluminum stub and covered with a thin gold layer to improve
electrical conductivity.
The nanoparticle morphology and size in the dry state were
analyzed using transmission electron microscopy (TEM, FEI Tecnai
F20) equipped with a Schottky emitter and operating at 120 and 200
keV. The powder (10 μL) was suspended in 5 mL of isopropanol and
treated with ultrasound. A droplet of the resulting finely dispersed
suspension was evaporated at room temperature and atmospheric
pressure on a holey carbon film supported by a copper grid. The
nanoparticle nanostructure was investigated by high-resolution TEM,
and energy-dispersive system (EDS) profiling with a spatial resolution
of 3 nm was recorded by scanning TEM (STEM) at 200 kV.
The specific surface area (SSA) of the powders was measured by
the nitrogen adsorption method, following the Brunauer−Emmett−
Teller model (Sorpty 1750, Carlo Erba, Milan, Italy).
The release of ions was evaluated by immersing tablets obtained
with the various HA powders (1 g each) consolidated by cold isostatic
pressing at 2500 bar with a final dimension of 20.5 mm Ø × 2 mm
height, a superficial area of 7.9 cm2, and an average residual porosity
of 52% into 5 mL of pH 7.4 buffer solution (Ca and Mg-free Hank’s
balanced salt solution) kept at 37 °C and gently shaken at 200 rpm. At
scheduled times (i.e., after 1, 2, 3, 7, 11, and 15 days), the solution
was removed and 5 mL of fresh solution was added to the tablets.
Similar experiments were carried out by immersing the tablets in
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osteogenic medium [minimum Eagle’s essential medium (αMEM)
supplemented with 10% FBS, 1% penicillin/streptomycin 100 U·
mL−1/100·μg·mL−1, 10 mM β-glycerophosphate, 50 μg/mL ascorbic
acid, and 100 nM dexamethasone]. The liquids containing the ions
released after the prefixed times were analyzed by ICP−OES, in
triplicate, for the quantitative determination of Ca, Mg, and Zn.
The ζ-potential distribution of dried powders suspended in N-(2-
hydroxyethyl)piperazine-N′-ethanesulfonic acid buffer at pH 7.4 was
measured by dynamic light scattering with a Zetasizer Nano ZS
instrument (Malvern Ltd., Worcestershire, U.K.) and quantified by
laser Doppler velocimetry as electrophoretic mobility using a
disposable electrophoretic cell (DTS1061, Malvern Ltd., Worcester-
shire, U.K.). Twenty runs of 3 s each were collected in each
measurement.
2.3. Cell Culture. Human adipose-derived mesenchymal stem
cells (ASCs) were purchased from ATCC and cultured following the
company indications. ASCs were seeded at 5.0 × 103 cells/cm2 and
cultured in osteogenic medium (αMEM supplemented with 10% FBS,
1% penicillin/streptomycin 100 U·mL−1/100 μg·mL−1, 10 mM β-
glycerophosphate, 50 μg/mL ascorbic acid, and 100 nM dexametha-
sone). Twenty four hours after the cell seeding, two different
concentrations (50 and 500 μg/mL) of selected apatites (HA as the
control, Zn-HA-1, and Zn-MCHA) were added and the cells left in
culture for 14 days.
2.4. Cell Viability Assay. After 1, 3, 7, and 14 days, cell viability
was investigated by MTT reagent (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay. MTT (20 μL, 5 mg/mL) was
added into each well; 2 h later, 200 μL of dimethylsulfoxide was
added to the cells, and absorbance was detected at 570 nm (A570)
using a Multiskan FC Microplate Photometer (Thermo Fisher
Scientific). This absorbance is directly proportional to the number
of metabolically active cells. Mean values of absorbance were
determined. Three samples per group were analyzed.
2.5. Cell Morphology Evaluation. After 3 days of culture, cell
cultures were washed in 1× PBS for 5 min, fixed in 4% (w/v)
paraformaldehyde for 15 min, and permeabilized with 0.1% (v/v)
Triton X-100 for 5 min. Fluorescein isothiocyanate-conjugated
phalloidin (38 nM, Invitrogen) was added for 20 min at room
temperature in the dark, and 4′,6-diamidino-2-phenylindole DAPI
300 nM (Invitrogen) for 5 min was used for nuclear staining. Images
were acquired by an Inverted Ti-E fluorescence microscope (Nikon).
The analysis was performed for all groups at both concentrations.
2.6. Quantitative Real-Time Polymerase Chain Reaction.
After 7 and 14 days, the total RNA of cells was extracted and purified
by Tri Reagent, followed by the Direct-zol RNA MiniPrep kit (Zymo
Research) according to manufacturer’s instructions. RNA (500 ng)
were reverse transcribed to cDNA using the High-Capacity cDNA
Reverse Transcription Kit, according to manufacturer’s instructions
(Life Technologies). Alkaline phosphatase (ALP, HS01029144) and
3-phosphate dehydrogenase (HS99999905) genes (Life Technolo-
gies) were quantified by the StepOne Real-Time PCR System
(Applied Biosystems). Experiment was done in triplicate using three
technical replicates for each experiment. Data were collected using the
StepOne software (v.2.2.2), and relative quantification was performed
using the comparative threshold (Ct) method (ΔΔCt), where the
relative gene expression level equals 2−ΔΔCt.16 HA samples were used
as the calibrator.
2.7. Immunofluorescence Analysis. After 7 days, the cells were
fixed in 4% (w/v) paraformaldehyde, blocked with 20% normal goat
serum, and permeabilized with 0.1% (v/v) Triton x-100. The cells
were incubated overnight at 4 °C, with antibodies anti-runt-related
transcription factor 2 (RUNX2) and collagen I (COL-1) (Abcam),
followed by incubation with secondary antibodies Alexa Fluor 488
goat anti-rabbit (Molecular Probes) and Cy3 sheep anti-mouse
(Molecular Probes) for 45 min at room temperature. Cell nuclei were
stained with DAPI 300 nM. Images of one sample per group were
acquired by an Inverted Ti-E fluorescence microscope (Nikon).
2.8. Statistical Analysis. Analysis of the effect of nanopowders on
cell viability and gene expression was made by two-way analysis of
variance, followed by Bonferroni’s post hoc test by the GraphPad
Prism software (version 6.0) with statistical significance set at p ≤
0.05. Results were expressed as mean ± standard error of the mean.
2.9. Antimicrobial Tests. To assess the effect of ion doping on
the antimicrobial properties of HA, specific tests were performed on
the multidoped ZnMCHA, single-doped Zn-HA-1 and Zn-HA-2, and
the undoped HA taken as the control. The selected materials were
tested against pathogenic yeasts (C. albicans) and against potentially
pathogenic bacteria, such as Gram-negative (E. coli and P. aeruginosa)
and Gram-positive bacteria (S. aureus). Two subcultures from the
stock culture by streaking onto tryptone soy agar (for bacteria) and
onto Sabouraud dextrose agar (for yeast Candida) were prepared and
incubated overnight. From one subculture (the working culture), a
loop full of bacterial cells was transferred into the diluent and
suspended. Each microbial test suspension was prepared by taking 1
mL of the diluent (tryptone sodium chloride solution) using a
mechanical shaker. The number of cells in the microbial suspension
was adjusted in the range from 5.3 × 106 to 6.7 × 106 cfu/mL for
bacteria and 6.0 × 105 cfu/mL for Candida by turbidimetry. For the
determination of the bactericidal effect, 400 μL of microbial
suspension was added to tablets prepared in the same manner as
for ion-release tests. The antibacterial tests were carried out in
triplicate on two different sets of materials: the first set (coded as
PRISTINE) was used as synthesized; the second set (coded as
AGED) was used after aging the apatite tablets into pH = 7.4 buffer
solution (Ca- and Mg-free Hank’s balanced salt solution) for 14 days,
that is, in the same medium used for the analysis of ion release. After
every contact time, through dilution, the total viable count was
calculated and expressed in cfu/mL. The reduction in viability was
calculated as N × 10−1 Na, where N and Na are the bacterial
concentrations (cfu/mL) at the beginning and after the test.
Figure 1. Left: XRD patterns of the studied materials. (a) HA, (b) Zn-HA-1, (c) Zn-HA-2, and (d) Zn-MCHA. Right: FTIR absorption spectra:
(a) HA, (b) Zn-HA-1, (c) Zn-HA-2, and (d) Zn-MCHA.
ACS Biomaterials Science & Engineering Article
DOI: 10.1021/acsbiomaterials.9b00893
ACS Biomater. Sci. Eng. XXXX, XXX, XXX−XXX
C
3. RESULTS
3.1. Physicochemical Characterization. XRD analysis
(Figure 1a) confirms that the HA phase is the only crystalline
component (PDF card #09-0432) of all the as-obtained
materials. The XRD spectra of the ion-doped materials are
characterized by broader patterns as compared with the
undoped HA. This effect can be ascribed to a reduction of the
crystalline domain size because of the presence of doping Mg2+
and Zn2+ ions as substitutes for Ca2+ and of CO3
2− ions for
PO4
3−, as also observed in previous works.10,14,20,28,29
FTIR spectra (Figure 1b) confirm the presence of the
characteristic absorption bands of the phosphate group at
980−1100 and 560−600 cm−1 typical of the HA phase. The
FTIR adsorption bands appear weakly resolved, typical for low-
crystalline materials, as confirmed by the splitting factors
reported in Table 1. In this respect, the multidoped HA
exhibits the lowest splitting factor. FTIR analysis also denotes
the presence of CO3
2− groups in all doped HA, attested by the
presence of absorption bands at ∼1450, 1430, and 870 cm−1,
belonging to CO3 groups substituting PO4
3− ions in the apatite
lattice (i.e., B-carbonation). The undoped HA also shows
typical bands related to B carbonation; such a spontaneous
incorporation of CO3
2− ions is commonly ascribed to the
dissolution of atmospheric carbon dioxide into the mother
solution during powder synthesis, as previously observed by
several works.14,27 B-carbonation is abundant in the newly
formed and immature bone and is considered as a key aspect
for the HA bioactivity because it strongly increases its
solubility at physiological environment and promotes osteo-
blast cell adhesion.21 In comparison with the undoped HA,
FTIR analysis also highlights the reduction of the OH−
absorption band at 3570 cm−1 in single-substituted Zn-HA-1
and Zn-HA-2 and, in higher extent, in Zn-MCHA (similar
content of Zn2+ as Zn-HA-1 but also containing Mg2+ and
CO3
2− ions). This finding is consistent with a previous study
highlighting a direct correlation between the crystal size
decrease and the hydroxylation extent in nanocrystalline HA.22
In our materials, a possible mechanism explaining the decrease
of the hydroxyl band is the charge compensation for the
carbonate ion uptake in the substitution of a phosphate group,
resulting in lack of a negative charge. The charge neutrality can
be restored by the concurrent elimination of one Ca2+ and
OH− ion for every PO4 ↔ CO3 exchange.
Crystallographic data obtained by the full profile analysis of
the XRD patterns in Figure 1 are reported in Table 1.
Specifically, the ion-doped HA powders show lattice
deformation, with a and c parameters steadily decreasing
with higher Zn content, particularly when Mg2+ ions were also
introduced, thus confirming the general trend observed in
previous studies where the doping was only with Zn2+ ions.21,28
The reduction of the cell volume (up to −1.3% in Zn-MCHA)
and of the average crystallite size is related to alteration of the
interatomic distances, which can be ascribed to the smaller
atomic radius of the doping ions with respect to calcium (i.e.,
Zn2+ = 88 pm and Mg2+ = 86 pm compared with Ca2+ = 114
pm) and phosphate ions (i.e., CO3
2− = 178 pm compared with
PO4
3− = 238 pm). In comparison with Ren et al. who prepared
Zn-doped HAs at 90 °C,21 the adoption of biomimetic
conditions for our synthesis induced very limited crystal
growth (1 order of magnitude smaller), thus with a specific
surface much closer to the natural bone.30,31 The crystalline
domain size along the two orthogonal axes of the hexagonal
HA lattice was measured by analyzing the broadening of the
(300) and (002) reflections (d ≈ 2.72 and ∼3.44 Å,
respectively; see D300 and D002 in Table 1). The undoped
HA shows a marked crystal growth along the c axis, typical of
the mature bone tissue,17 and conversely, the ion-doped HA
powders show a reduced crystal anisotropy and a shape factor
(i.e., D300/D002) closer to 1. This effect is more evident in the
Zn-MCHA phase as a result of multiple-ion substitutions
increasing the crystal disorder and possibly limiting the crystal
growth along the 00l direction. Therefore, our synthesis
conditions can yield multidoped HAs mimicking the crystal
state of the immature bone tissue, which is metabolically very
active;17,31 hence, it may represent a source of enhanced
bioactivity.
Chemical analysis by ICP−OES, reported in Table 2,
confirms the presence of Mg2+ and Zn2+ ions in the as-obtained
materials. In Zn-HA-1 and Zn-HA-2, the yield of Zn doping is
above 90%. In the case of Zn-MCHA codoped with Zn2+ and
Mg2+, the yield of zinc entering is reduced and part of the
introduced Mg2+ ions (∼7 mol%) is as well included in the HA
structure. The extent of Mg entered in Zn-MCHA is
comparable with that obtained in a previous study, where
Mg−CO3-doped HA was prepared by a similar synthesis
route;15 therefore, we can infer that the doping with Zn2+ ions
does not alter the capability of Mg2+ ions to enter in the HA
structure as a dopant. The decrease of the calcium content
with the increase of Zn doping sustains the hypothesis that
Zn2+ ions substitute Ca2+ in the lattice. Regarding Mg2+,
previous studies reported that a lattice substitution of up to
∼10% can be obtained in Mg-doped HA phases;12 however, in
the case of codoping with divalent cations, both Zn2+ and Mg2+
are expected to compete to occupy the same crystal sites of
Table 1. Crystallographic Data of the Studied Materials
sample a (Å) c (Å) c/a cell vol (Å3) Dav (nm) D300 (nm) D002 (nm) shape factor splitting factor
HA 9.432(1) 6.895(1) 0.731(1) 531.2 ± 0.1 21.3 ± 2.1 22.8 ± 0.4 56.0 ± 1.5 2.46 3.68
Zn-HA-1 9.423(5) 6.887(4) 0.730(9) 529.7 ± 0.2 15.4 ± 1.2 16.7 ± 0.8 31.2 ± 0.9 1.87 3.81
Zn-HA-2 9.404(9) 6.885(5) 0.728(3) 527.3 ± 0.1 13.1 ± 1.7 16.7 ± 1.0 31.7 ± 0.8 1.90 3.58
Zn-MCHA 9.378(6) 6.880(5) 0.733(6) 524.1 ± 0.2 11.6 ± 1.6 18.2 ± 1.1 25.6 ± 0.8 1.41 3.13
Table 2. Ion Content in the As-Obtained Materials with Respect to the Nominal Amount Introduced in the Reaction Vessel
samples Ca/P (mol) Ca wt % nominal XMg actual XMg nominal XZn actual XZn nominal XCO3 actual XCO3 CO3 wt %
HA 1.69 36.5 0.070 2.41
Zn-HA-1 1.76 34.2 0.05 0.049 0.084 3.27
Zn-HA-2 1.59 25.6 0.10 0.094 0.093 2.17
Zn-MCHA 1.71 30.4 0.15 0.071 0.05 0.040 0.15 0.135 5.39
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Ca2+, and therefore it can be hypothesized that in Zn-MCHA,
at least a fraction of doping ions does not occupy substitutional
positions in the HA lattice sites.
TGA (Figure 2) shows that all of the studied materials
undergo a weight loss of ∼10−15% upon heating up to 1100
°C. Typically, all TG spectra show a weight loss of ∼6−7 wt%
up to ∼300 °C (Table 3), which was found to be the upper
limit for the evaporation of entrapped H2O molecules.
32 Ion-
doped HA powders show higher water content, particularly the
multidoped Zn-MCHA. Further weight loss, up to ∼400 °C, is
ascribed to the condensation of HPO4
2− groups, exposed on
the apatite surface, into pyrophosphate (P2O7) groups
12,15
Also in this case, the doped samples show higher weight loss
than the undoped HA, with small differences between Zn-HA-
1 and Zn-HA-2, whereas the multidoped Zn-MCHA also
shows the highest weight loss within this temperature range.
The larger HPO4
2− content detected in the multidoped Zn-
MCHA can be ascribed to the enhanced population of the
surface with positively charged groups such as Ca2+ ions and
Mg2+ ions, both able to link HPO4
2−, a phenomenon also
observed in a previous study on the Mg-doped HA phase.12
The presence of Mg2+ ions on the Zn-MCHA surface is also
supported by the higher amount of bound water detected by
TGA since Mg2+ ions are characterized by greater affinity with
H2O molecules with respect to Ca
2+.33 Finally, TGA analysis
also reports weight loss in the range of 600−1100 °C which,
according to ref 27, is related to the CO2 release provoked by
the decomposition of CO3
2− substituting PO4
3− in the apatite
structure (B-carbonation).
3.2. Morphological Characterization. SEM analysis of
the samples reports a morphology typically characterized by
rounded, slightly elongated nanoparticles (mean size: 20−50
nm) clustered into micron-size agglomerates (Figure 3). The
small size of the nanoparticles is consistent with the high SSA
of the apatite powders, as found by the nitrogen adsorption
analysis (i.e., HA: 162.34 m2/g; Zn-HA-1: 170.18 m2/g; Zn-
HA-2: 169.66 m2/g; Zn-MCHA: 188.56 m2/g). These findings
are consistent with the smaller crystallite size detected in the
doped apatites (Table 1).
TEM pictures of Zn-MCHA and Zn-HA-2, as representative
of the single-doped Zn-HAs, are reported in Figure 4. The
morphology of the two powders slightly differs. Zn-MCHA is
composed of platelike particles often agglomerated, with the
major axis ranging between 50 and 75 nm and the minor axis
between 10 and 20 nm. Zn-HA-2 is composed of rodlike
particles, with the major axis size in the 75−120 nm range and
a much smaller minor axis ranging between 10 and 20 nm.
These results are in good agreement with the crystallite size
and shape factor estimated from the XRD analysis (Table 1).
The aggregation observed in the TEM picture is due to the
prevalence of the electrostatic interactions of nanoparticle
Figure 2. TG spectra of: (a) HA, (b) Zn-HA-1, (c) Zn-HA-2, and (d) Zn-MCHA.
Table 3. Weight Loss (%) Recorded at Defined
Temperatures during TGA
sample/temp (°C) 300 400 600 1100
HA 6.06 6.75 7.44 9.21
Zn-HA-1 6.97 7.46 8.30 10.70
Zn-HA-2 7.02 7.58 8.34 9.93
Zn-MCHA 7.74 8.54 9.38 13.33
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surface in the dry state, and hence it is not fully representative
of the actual nanoparticle condition in aqueous dispersion.
STEM picture and the EDS drift-corrected spectrum profile
collected on sample Zn-HA-2 are reported in Figure 5. The Ca,
P, and Zn profiles (Figure 5b) acquired along the yellow line
highlighted in Figure 5a clearly shows the increase of the Zn
signal in the inner part of the nanoparticle as well as the Ca
and P compositions. In detail, the profiles show the
compositional changes from the core to the surface of the
nanoparticles, with Ca signals being more intense on the
border and, conversely, Zn signals being more intense in the
central part.
Figure 6 highlights that Zn-MCHA is constituted of a
crystalline core surrounded by a more disordered region, as
shown by high-resolution TEM images (Figure 6a,b) and
confirmed by the STEM image in Figure 6c, showing a lower
electron dense region in the border of the nanoparticle with
respect to the nanoparticle core and thus confirming the
presence of less crystalline and less ordered regions on the
apatite surface.
3.3. Evaluation of Ion-Exchange Profiles. The release of
ions from the undoped HA, Zn-HA-1, Zn-HA-2, and Zn-
MCHA was investigated to obtain the biosolubility profile in
the physiological environment (Hank’s balanced salt solution)
and to assess the ability to exchange ions when soaked in
αMEM cell culture media. Figure 7 shows the release profile of
Ca2+ and Mg2+ ions in Hank’s solution, expressed in absolute
values (Figure 7a) and as a percentage of the initial ion content
in the material (Figure 7b). No detectable release of Zn2+ ions
was observed along the whole experiment; conversely, Mg2+
ions were released in a relatively large extent over time. The
release of Ca2+ and Mg2+ ions can be described by two distinct
mechanisms. In fact, a burst ion release was detected during
the first 3 days, followed by a slower release kinetic, suggesting
that within this stage, the release process involves ions
Figure 3. SEM images of (a) undoped HA, (b) Zn-HA-1, (c) Zn-HA-
2, and (d) Zn-MCHA powders.
Figure 4. TEM pictures of Zn-MCHA (a) and Zn-HA-2 (b). In the
insets, the relative selected area electron diffraction patterns are
reported.
Figure 5. (a) STEM micrograph of a single Zn-HA-2 nanoparticle. (b) EDS profile taken along the yellow line having a length of 40 nm reported in
panel (a).
Figure 6. High-resolution TEM/STEM analysis of the Zn-MCHA
nanoparticle. (a) High-resolution TEM image; (b) detail showing the
apatite lattice within the particle core, with the typical interplanar
distance of the [002] reflection; (c) STEM image of a single Zn-
MCHA nanoparticle.
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characterized by relatively weaker chemical bonds. Such ions
are likely located in surface regions characterized by enhanced
crystal disorder, as evidenced by the STEM analysis in Figure
6. In the subsequent stage (i.e., days 3−14), the release of both
Ca2+ and Mg2+ ions slackened; therefore, it can be ascribed to
the dissolution of inner, more crystalline, and stable regions.
Taking into account that no Zn2+ ion release was detected, we
can hypothesize that Zn2+ ions do not populate such a
disordered surface layer but are entirely located in the more
energetically stable substitutional positions in the HA lattice.
This assumption is confirmed by the TEM analysis in Figure
5b, showing Zn located prevalently in the inner regions of the
HA structure. B-carbonated Zn-MCHA shows ion release
extent comparable with undoped HA and single-doped Zn-
HAs. This behavior is in contrast with previous studies
reporting a markedly higher ion release in carbonated apatites
in comparison with noncarbonated ones.14,27,34 Nevertheless,
similar studies were never carried on apatites codoped with
Zn2+, Mg2+, and CO3
2− ions; the unexpectedly low solubility of
the carbonated Zn-MCHA can be directly related to the
phenomenon of Zn2+ ↔ Ca2+ ion exchange in the lattice. The
obtained data support the hypothesis that such substitution
can sort interlinked effects as it (i) stabilizes the apatite crystal,
counteracting the destabilizing effects due to substitution with
CO3
2 while at the same time it (ii) reduces the crystal size, (iii)
increases the specific surface and crystal disorder on the
surface, and finally (iv) promotes the release of ions from the
apatitic structure.
The apatite powders were soaked into Ca- and Mg-free
Hank’s solution, and the ζ-potential was measured at prefixed
timepoints (Table 4). The results show that all apatites exhibit
a high negative charge, steadily decreasing with the soaking
time but remaining far from electrical neutrality even after 14
days. This behavior can be ascribed to a dynamic equilibrium
established on the apatite surface layer when immersed into
such aqueous media, related to continuous and evolving ion
mobility. In the undoped HA, the surface charge reduction is
much faster than in ion-doped HAs; besides Ca2+, in the
undoped HA most of the mobile ions are likely HPO4
2− and
PO4
3− groups commonly present on the surface of nano-
crystalline apatites.35 The negative charge of the ion-doped
HAs decreases toward more negative values with the zinc
content (i.e., Zn-HA-2 > Zn-HA-1 > Zn-MCHA > HA, see
also Figure 7b). This finding shows that the extent of Zn2+ ion
doping is related to enhanced surface activity in terms of
exposed charges and improves the ability to exchange bioactive
ions with aqueous media.
The surface activity of the synthesized samples was also
evaluated by soaking in αMEM cell culture medium to evaluate
the ability of ion exchange in the presence of cells. Different
from the test performed in ion-free Hank’s balanced salt
solution, the concentration of Ca2+ and Mg2+ ions in αMEM
pushes ion absorption rather than release (Figure 8). The tests
show continuous absorption of Ca2+ and Mg2+ ions already
present in the fluid, particularly within the first 3 days; later,
the absorption process reaches a saturation level and is
described by a plateau. Ca2+ ions are absorbed in a similar
extent by the three tested apatite powders (Figure 8a). The
extent of Ca2+ ion adsorption in percentage follows the trend
of Ca2+ release detected in the experiments carried out in
Hank’s balanced salt solution (i.e., Zn-HA-1 > Zn-MCHA >
HA, see Figure 7b). This confirms the correlation between the
ion mobility in the apatites and the extent of Zn ↔ Ca
exchange in the lattice. The absorption of Mg2+ ions is
Figure 7. Ion release in physiological fluid: (a) absolute values of released ions; (b) percentage values of released ions with respect to those present
in the as-obtained material. Note that no Zn release could be observed in any material.
Table 4. ζ-Potential of the As-Obtained Materials vs
Soaking Time
ζ-potential (mV)
sample/time 0 1 d 4 d 7 d 14 d
HA −15.53 −14.20 −13.22 −11.53 −7.91
ZnHA-1 −17.20 −16.37 −15.18 −13.60 −13.50
ZnHA-2 −19.37 −17.50 −17.03 −16.57 −16.33
Zn-MCHA −14.60 −13.20 −12.76 −12.00 −11.03
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observed in all of the apatites but less evident in the
multidoped Zn-MCHA, thus suggesting that Zn-MCHA
already exposes a significant fraction of Mg2+ charges on the
surface (Figure 8b). The ability of the studied apatites to
expose Mg2+ ions permit to greatly increase their affinity with
cells and enhance bioactivity.33,36
3.4. Biological Characterization. In vitro analysis with
human adipose stem cells (ASCs) was carried out on three
selected materials: Zn-HA-1, Zn-MCHA, and the undoped HA
chosen as the reference. The ASC behavior in contact with two
different concentrations of powders was investigated in vitro
looking at the cell viability, cell morphology, and expression of
ALP osteogenic-related gene and COL-1 and Runx2 protein
evaluation up to 14 days of culture. The quantification of
metabolically active cells shows a significant enhancement in
cell proliferation induced by the presence of Zn and Mg. The
effect induced by Zn seems to be dose-dependent; in fact, a
significant difference was observed after 7 days of culture in the
Figure 8. Ion-exchange profile evaluated in αMEM cell culture medium.
Figure 9. Analysis of cell proliferation by the MTT assay after 1, 3, 7, and 14 days of ASCs seeded with 50 and 500 μg/mL of the samples. *p ≤
0.05; **p ≤ 0.01, and ***p ≤ 0.001. n = 3.
Figure 10. Relative quantification (2−ΔΔCt) of ALP expression after 7 and 14 days of ASCs cultured in contact with all samples. The graphs report
the mean and standard error of the technical triplicate of ALP with respect to the expression of cells in contact with HA, used as the control. (*p ≤
0.05; ***p ≤ 0.001; ****p ≤ 0.0001).
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presence of 500 μg/mL, whereas in the presence of 50 μg/mL,
the induction of proliferation is evident on day 14 and it seems
related to the presence of Mg (Figure 9). This confirms the
direct effect of Zn2+ doping to enhance the surface activity of
the HAs that this test showed to be beneficial for stem cell
proliferation. The effect of Mg2+ ions exposure is also
evidenced by the increased stem cell proliferation in Zn-
MCHA at any dose, particularly effective in the long term.
In order to assess any osteoinductive effects of the new
phases on ASC differentiation, gene expression analysis of ALP
was evaluated by quantitative polymerase chain reaction
(Figure 10), and RUNX2 and COL-1 proteins were
qualitatively detected by the immunofluorescent analysis
(Figure 11). All osteogenic markers appear to be upregulated
in the cells cultured with 500 μg/mL of both Zn-HA-1 and Zn-
MCHA, indicating that the doping with Zn2+ acts as an
osteoinductive factor, whereas the exposure of Mg2+ ions
further strengthens the osteo-differentiative ability, particularly
if present in relevant doses. These findings suggest that
codoping with Zn2+ and Mg2+ can greatly enhance the ability of
HA to sustain stem cell proliferation and appropriate
differentiation for an extended time lapse and thus promote
new bone tissue formation.
3.5. Antimicrobial Test. The antimicrobial effect of the
ion-doped Zn-HA-1, Zn-HA-2, and Zn-MCHA materials, in
comparison with undoped HA, was tested with four different
bacterial strains: P. aeruginosa, E. coli, S. aureus, that is, two
Gram− and one Gram+ bacteria, respectively, and a yeast, C.
albicans. In order to evaluate the effect of ions released or
exposed on the apatite surface, when soaked in the culture
medium, the antimicrobial tests were carried out on two
different sets of materials: the first set (coded as PRISTINE)
was used as obtained; the second set (coded as AGED) was
used after aging into pH 7.4 buffer solution (Ca- and Mg-free
Hank’s balanced salt solution) for 14 days, that is, under the
same experimental conditions and timing adopted with the
ion-release test described in Figure 7, to test the bioactivity of
the apatites after elimination of a significant extent of labile
ions from the apatite surface and subsurface regions.
PRISTINE samples exhibit remarkable ability of bacterial
inhibition after 24 h (Figure 12), particularly, more rapid and
enhanced antibacterial activity is shown by the multidoped Zn-
MCHA (99.999% of bacterial reduction) with respect to the
control undoped HA, which shows the lowest effectiveness at
all of the investigated timepoints and the lowest antiprolifer-
ative ability after 24 h for all of the considered infective strains.
Figure 13 shows that the AGED Zn-MCHA retains relevant
ability of microbial inhibition at a level similar to the
PRISTINE material. The remaining materials of the AGED
group shows marked reduction of their antibacterial activity
compared with the PRISTINE group, particularly for S. aureus
and E. coli. Remarkably, single-doped Zn-HA materials (both
Zn-HA-1 and Zn-HA-2) show high effectiveness against the
yeast C. albicans. These results suggest that the doping with
Zn2+ ions is relevant to confer enhanced antibacterial ability to
HA; however, it appears that Mg2+ ionsexposed at the
surface or exchangedare able to further enhance antibacterial
ability and effectiveness over a wider spectrum of infective
strains.
4. DISCUSSION
The present study shows that the investigated ion-doped HAs
have excellent osteoinductive properties and, at the same time,
enhanced inhibitory abilities against various pathogens selected
among the most frequent responsible for nosocomial
infections. The key factor at the basis of enhanced
biofunctionalities of multidoped HA is the increased lattice
disorder induced by the Zn ↔ Ca exchange within the apatite
lattice and the consequent increase of the surface charge and
ability of prolonged exchange of bioactive ions such as Ca2+,
Mg2+, and HPO4
2−, which are known as biospecific chemical
signals active in bone regeneration.
Physicochemical mechanisms related to enhanced osteo-
genic and antimicrobial properties can be related to the
location of the doping ions into the structure of nanocrystalline
HAs and, consequently, to their mobility. During the formation
of the apatite phase by the wet neutralization method, Zn2+
ions occupy substitutional positions at calcium lattice sites.
This provokes the segregation of Ca2+ ions at surface regions
characterized by low-range crystal order and weaker chemical
bonds, thus enhancing the ability of ion exchange in aqueous
media. In HA samples doped with only Zn2+ ions, the exchange
process involves only Ca2+ ions, as Zn2+ ions occupy stable
crystal sites and are not released in any amounts even after 14
days of soaking in a physiological medium. Conversely,
considering the sustained release profile of Mg2+ ions, we
can suppose that they are relatively weakly bound to the apatite
structure and thus, in combination with Ca2+, they could be
involved in a continuous ion-exchange process, functioning as
bioactive chemical signals for human cells and bacteria.
With stem cells, such signals greatly improve the viability,
proliferation, and osteogenic character, particularly for the
multidoped Zn-MCHA phase. The adoption of bodylike
Figure 11. Analysis of cell morphology on day 3 seeded with the
highest concentration of samples (A−C). Phalloidin in green stains
for actin filaments and DAPI in blue stains for cell nuclei.
Immunofluorescent analysis of COL-1 (D−F) on day 7 (500 μg/
mL). Staining of COL-1 (in red) and cell nuclei (in blue).
Immunofluorescent analysis of RUNX2 (G−I) on day 7 (500 μg/
mL). Staining of RUNX2 (in red) and cell nuclei (in blue). (A,D,G)
HA group. (B,E,H) Zn-HA. (C,F,I) Zn-MCHA. Scale bars: (A−C) 80
μm; (D−I) 50 μm.
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temperature conditions for HA synthesis allowed to obtain a
nanocrystalline mineral phase with physicochemical properties,
mimicking the biologic apatite present in the immature bone
tissue. B-type carbonation, the presence and exchange of
doping Mg2+ ions, reduced hydroxylation extent, and very
small crystal size are all features previously reported as triggers
for new bone formation.13,37−40 Our result indicates that the
use of biomaterials combining all these features is promising to
significantly enhance the bone-forming ability of human stem
cells, as demonstrated by the upregulation of specific
osteogenic markers (i.e., ALP, RUNX2, and COL1). It is
well known, in fact, that the presence of ALP and RUNX2
activity is explicitly required to trigger the initial osteogenic
regulatory network and direct the bone developmental
program, while the production of COL-1 confirms the
differentiation into osteogenic lineage of ASCs.41−43
Regarding the effect on pathogens, previous studies
investigated Zn-doped HA as an antibacterial material. In
fact, Zn2+ can interact with bacterial cytoplasm and proteins,
thus inhibiting the uptake of metal ions relevant for bacterial
metabolism such as Mn2+.44 Furthermore, Zn2+ ions can easily
bind to the negatively charged bacterial membrane and prevent
bacterial adhesion and biofilm formation.45,46 However, our
results show that Zn2+ ions are not released in any extent but,
on the other hand, they enhanced the release of divalent ions
such as Ca2+ and Mg2+. Thus, we can hypothesize that the
release of ions such as Ca2+ and Mg2+ could be effective in
inhibiting bacterial viability by activation of similar mecha-
nisms as those observed by Couñago et al. who tested Zn2+
Figure 12. Microbial reduction for all infective strains in the PRISTINE materials.
Figure 13. Microbial reduction for all infective strains in the AGED materials.
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ions directly introduced in the bacterial culture.44 In fact, the
antimicrobial ability is significantly enhanced in the multi-
doped Zn-MCHA powder in comparison with single-doped
Zn-HA-1, since complete eradication of all tested infective
strains was achieved within only 12 h. Remarkably, Zn-MCHA
shows excellent behavior even when tested in its AGED form
(Figure 13), confirming its ability to reduce the majority of
potentially pathogenic bacteria by 99.999% within 12 h, with
particular respect to the Gram-negative E. coli and the Gram-
positive S. aureus strains, against which Zn-MCHA shows
much higher effectiveness than the other tested materials. This
latter case is significant, as HA was previously reported as
ineffective against various Gram-positive bacteria including S.
aureus.7 However, in that previous study, the HA used for the
test was well crystalline, in consequence of its synthesis carried
out at 60−80 °C. In the same study, amorphous CaPs, a highly
bioactive material characterized by very low crystallinity,
reported instead good effectiveness also against Gram+
bacteria.
It can be devised, therefore, that low crystallinity extent and
high ion mobility are key features to exhibit enhanced
biofunctionality, particularly, we observed excellent eukaryotic
versus prokaryotic cell selectivity related to improved
osteogenic and antimicrobial ability, particularly in the
multidoped Zn-MCHA. Such a condition was obtained, thanks
to the use of a low synthesis temperature and multiple-ion
doping, through which it was possible to tailor relevant
physicochemical features such as (i) high SSA and charge; (ii)
high mobility of bioactive ions from the apatite surface and
subsurface; and (iii) type and amount of doping ions. Besides
providing good affinity with stem cell polarity, the high surface
charge can provide bioelectric effect contrasting bacterial
biofilm formation.47 This could be particularly effective in the
ion-doped apatites, which show higher surface charge. The
design of nanocrystalline apatites permitting the exchange of
foreign divalent ions having specific biologic functions can
bring to a variety of devices intended for specific applications
in medicine. For instance, the doping with Mg2+ and/or Sr2+
can yield anti-osteoporotic effect48−50 while preventing, at the
same time, secondary complications such as infections that are
a primary cause of failure of implanted devices. In particular,
the long lasting bioactivity and multifunctional ability shown
by Zn-MCHA make it very promising for frontier applications
in medicine, to provide sustained therapeutic and protective
effects in the case of bone reconstruction/regeneration
procedures, or as a coating for metal-based implants to
enhance osteointegration and primary fixation with a
significant cut of postoperatory infective phenomena.
Despite several studies carried out to date, a substantial
agreement has not yet been found in defining which
physicochemical features a biomaterial should exhibit to
ensure effective advantages to prevent infections and biofilm
formation.51,52 In this respect, the present work highlights that
nanomaterials with a highly active surface such as ion-doped
nanocrystalline apatites can exert substantial antimicrobial
effect by aid of inherent molecular mechanisms mediated by
divalent ions, which also result in enhanced safety for stem
cells and in increased regenerative potential. Such molecular
mechanisms can act on a wider range of targets than narrow-
spectrum antibiotics, and therefore, the use of multidoped
apatites can be effective in the prevention of bacterial
infections over a broad spectrum and also useful to overcome
multidrug resistance now typical of many micro-organisms.53
This hypothesis requires further studies and dedicated in vivo
trials to confirm the enhanced multifunctional ability of
multidoped biomimetic apatites in real clinical cases. Success
in this respect may open a new class of biomaterials able to
solve crucial and impellent medical needs andnot negli-
giblewith marketability facilitated by easy translational
processes (i.e., the product is a purely inorganic HA) and
with perspective of wide applications in many different fields,
where microbial-free surfaces are needed.
5. CONCLUSIONS
The ever raising occurrence of nosocomial infections and
related diseases is pushing material scientists to develop new
therapeutic biomaterials capable of effective and durable
protection against bacterial proliferation and biofilm formation.
In this paper, multidoped nanocrystalline HA shows very
promising features for primary versus pathogenic cell
selectivity, as attested by effective cell-instructing and long-
term antimicrobial abilities. Relevant physicochemical mecha-
nisms at the base of such unique properties are related to
nanocrystallinity, high SSA and surface charge, and triggering
of ion-exchange phenomena (particularly, Mg2+) exerting
stimuli on stem cells and pathogens. These features were
obtained thanks to the incorporation of multiple doping ions;
specifically, the doping with Zn2+ induced the segregation of
bioactive ions on the material surface making them available
for exchange with physiological fluids, promising to be effective
to sustain bone regeneration with reduced complications in the
postoperative period. Particularly, since a marked anti-infective
ability was obtained without using any antibiotic drugs, this is
promising to prevent bacterial antibiotic resistance in hospitals,
which is becoming a pandemic problem. Therefore, biomi-
metic materials such as multidoped HA phases are relevant
candidates for the development of a new generation of medical
devices with improved therapeutic effectiveness and for solving
crucial and still unmet clinical needs.
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